関連する実験動画

Updated: Feb 14, 2026

Experimental Assessment of Mouse Sociability Using an Automated Image Processing Approach
08:24

Experimental Assessment of Mouse Sociability Using an Automated Image Processing Approach

Published on: May 15, 2016

9.0K

新しいHPTLC画像分析アプローチで,アドレナリン作用薬の相互作用と抗酸化プロフィールを評価する

Larisa Silveșan1, Claudia Cimpoiu1, Dorina Casoni1

  • 1Babeş-Bolyai University, Faculty of Chemistry and Chemical Engineering, 11 Arany Janos, Cluj-Napoca, 400028, Romania; Research Center for Advanced Chemical Analysis, Instrumentation and Chemometrics-ANALYTICA, Babeş-Bolyai University, Cluj-Napoca, Romania.

Journal of chromatography. A
|February 12, 2026
PubMed
まとめ

この研究では,アドレナージ薬の抗酸化活性を評価するために,画像分析 (HPTLC-IA) による新しい高性能薄層染色法が導入されました. このアプローチは,静止相相互作用が抗酸化剤のプロフィールにどのように重要な影響を及ぼすかを明らかにします.

キーワード:
ABTS ((+•) アッセイによるアドレナジック薬は,アドレナジック薬です.抗酸化物質の活動がある.DPPH ((•) アッセイによる.HPTLC-IAによる分析シミュレートされた生理学的条件.

さらに関連する動画

Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis08:05

Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis

Published on: May 19, 2021

4.1K
Eukaryotic Polyribosome Profile Analysis09:16

Eukaryotic Polyribosome Profile Analysis

Published on: June 15, 2010

53.4K

関連する概念動画

Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
2
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
469
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.0K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.6K
Drug Dissolution: Requirements and Profile Comparison01:14

Drug Dissolution: Requirements and Profile Comparison

The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
289
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
617